NYSE:PRGO - Perrigo Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$45.97 +1.10 (+2.45 %)
(As of 01/20/2019 04:00 PM ET)
Previous Close$45.97
Today's Range$44.73 - $46.08
52-Week Range$36.28 - $95.93
Volume1.41 million shs
Average Volume2.68 million shs
Market Capitalization$6.25 billion
P/E Ratio9.32
Dividend Yield1.65%
Beta1.1
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments. It offers OTC products in cough, cold, allergy, sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, diagnostic, lifestyle, personal care and derma-therapeutics, natural health and vitamins, and anti-parasite categories. The company also develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, oral solid dosage forms, and oral liquid formulations. In addition, it offers contract manufacturing services. The company offers its products through retail drug, supermarket, and mass merchandise chains; hospitals; pharmacies; wholesalers; drug and grocery stores; and para pharmacies, as well as through a network of pharmacy sales force in North America, Europe, Australia, Israel, and China. Perrigo Company plc has a collaborative agreement with the Sol-Gel Technologies Ltd. for the development, manufacturing, and commercialization of an ivermectin cream in the United States. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Receive PRGO News and Ratings via Email

Sign-up to receive the latest news and ratings for PRGO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
CUSIP71429010
Phone353-1709-4000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.95 billion
Cash Flow$7.9948 per share
Book Value$43.81 per share

Profitability

Net Income$119.60 million

Miscellaneous

Employees10,400
Market Cap$6.25 billion
OptionableOptionable

Perrigo (NYSE:PRGO) Frequently Asked Questions

What is Perrigo's stock symbol?

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

How often does Perrigo pay dividends? What is the dividend yield for Perrigo?

Perrigo announced a quarterly dividend on Wednesday, October 31st. Shareholders of record on Friday, November 30th will be given a dividend of $0.19 per share on Tuesday, December 18th. This represents a $0.76 annualized dividend and a yield of 1.65%. The ex-dividend date of this dividend is Thursday, November 29th. View Perrigo's Dividend History.

How were Perrigo's earnings last quarter?

Perrigo Company PLC (NYSE:PRGO) posted its earnings results on Thursday, November, 8th. The company reported $1.09 earnings per share for the quarter, beating analysts' consensus estimates of $1.05 by $0.04. The business earned $1.13 billion during the quarter, compared to the consensus estimate of $1.17 billion. Perrigo had a net margin of 2.54% and a return on equity of 11.32%. The company's quarterly revenue was down 8.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.39 EPS. View Perrigo's Earnings History.

When is Perrigo's next earnings date?

Perrigo is scheduled to release their next quarterly earnings announcement on Thursday, March 7th 2019. View Earnings Estimates for Perrigo.

What guidance has Perrigo issued on next quarter's earnings?

Perrigo updated its FY18 earnings guidance on Thursday, November, 8th. The company provided earnings per share guidance of $4.45-4.65 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.86. The company issued revenue guidance of ~$4.72 billion, compared to the consensus revenue estimate of $4.87 billion.Perrigo also updated its FY 2018 guidance to $4.45-4.65 EPS.

What price target have analysts set for PRGO?

13 analysts have issued 1-year price targets for Perrigo's stock. Their forecasts range from $46.00 to $110.00. On average, they expect Perrigo's stock price to reach $77.3571 in the next twelve months. This suggests a possible upside of 68.3% from the stock's current price. View Analyst Price Targets for Perrigo.

What is the consensus analysts' recommendation for Perrigo?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last year. There are currently 1 sell rating, 10 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Perrigo.

Has Perrigo been receiving favorable news coverage?

News coverage about PRGO stock has been trending neutral recently, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Perrigo earned a media sentiment score of 0.1 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 4.0 out of 10, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

Are investors shorting Perrigo?

Perrigo saw a decline in short interest during the month of December. As of December 31st, there was short interest totalling 5,474,515 shares, a decline of 37.7% from the December 14th total of 8,791,586 shares. Based on an average trading volume of 3,537,573 shares, the short-interest ratio is presently 1.5 days. Approximately 4.0% of the shares of the company are short sold. View Perrigo's Current Options Chain.

Who are some of Perrigo's key competitors?

Who are Perrigo's key executives?

Perrigo's management team includes the folowing people:
  • Mr. Ronald L. Winowiecki, Chief Financial Officer (Age 52)
  • Mr. Todd W. Kingma, Exec. VP, Gen. Counsel & Sec. (Age 58)
  • Mr. Sharon Kochan, Exec. VP & Pres of Branded Consumer Healthcare and International (Age 50)
  • Mr. Jeffrey R. Needham, Exec. VP & Pres of Consumer Healthcare Americas (Age 62)
  • Mr. Murray S. Kessler, CEO, Pres & Director (Age 58)

Who are Perrigo's major shareholders?

Perrigo's stock is owned by a number of of institutional and retail investors. Top institutional investors include Nippon Life Global Investors Americas Inc. (0.03%), State of Alaska Department of Revenue (0.03%), Nisa Investment Advisors LLC (0.02%), Moon Capital Management LLC (0.02%), Meeder Asset Management Inc. (0.02%) and Louisiana State Employees Retirement System (0.00%). Company insiders that own Perrigo stock include Geoffrey M Parker, Jeffrey C Smith, Jeffrey Needham, John Wesolowski, Murray S Kessler, Sharon Kochan, Svend Andersen, Thomas Farrington, Todd W Kingma and Uwe Roehrhoff. View Institutional Ownership Trends for Perrigo.

Which major investors are selling Perrigo stock?

PRGO stock was sold by a variety of institutional investors in the last quarter, including Moon Capital Management LLC and Louisiana State Employees Retirement System. View Insider Buying and Selling for Perrigo.

Which major investors are buying Perrigo stock?

PRGO stock was acquired by a variety of institutional investors in the last quarter, including Meeder Asset Management Inc., Nippon Life Global Investors Americas Inc., State of Alaska Department of Revenue and Nisa Investment Advisors LLC. Company insiders that have bought Perrigo stock in the last two years include Geoffrey M Parker, Jeffrey C Smith, John Wesolowski, Murray S Kessler, Svend Andersen, Todd W Kingma and Uwe Roehrhoff. View Insider Buying and Selling for Perrigo.

How do I buy shares of Perrigo?

Shares of PRGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Perrigo's stock price today?

One share of PRGO stock can currently be purchased for approximately $45.97.

How big of a company is Perrigo?

Perrigo has a market capitalization of $6.25 billion and generates $4.95 billion in revenue each year. The company earns $119.60 million in net income (profit) each year or $4.93 on an earnings per share basis. Perrigo employs 10,400 workers across the globe.

What is Perrigo's official website?

The official website for Perrigo is http://www.perrigo.com.

How can I contact Perrigo?

Perrigo's mailing address is TREASURY BUILDING LOWER GRAND CANAL STREET, DUBLIN L2, 49010. The company can be reached via phone at 353-1709-4000 or via email at [email protected]


MarketBeat Community Rating for Perrigo (NYSE PRGO)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  648 (Vote Outperform)
Underperform Votes:  616 (Vote Underperform)
Total Votes:  1,264
MarketBeat's community ratings are surveys of what our community members think about Perrigo and other stocks. Vote "Outperform" if you believe PRGO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRGO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel